News | December 15, 2022
Kerala Ayurveda receives US patent for its herbal formulation
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
He has global experience in strategic and operational leadership including at Board, CEO and Senior Corporate levels
Tambe has been with Biocon since 1997 and has held diverse leadership and operational roles.
Steve joins Sai Life Sciences from GlaxoSmithKline (GSK) where he was a department head and member of the global chemical development leadership team.
Joint Drugs Controller (India) Dr PBN Prasad shared his views about working during harsh COVID-19 pandemic days
First PARP inhibitor to demonstrate clinical benefit in radiographic progression-free survival in combination with a new hormonal agent with or without homologous recombination repair gene mutations
Phase III trial also demonstrated a statistically significant reduction (14%) in hospitalization for any cause, bringing potential relief for patients and reducing burden on healthcare systems
Separate Phase 3 study evaluating 200 days of therapy with PREVYMIS in HSCT recipients at high risk of late clinically significant CMV infection recently completed, meeting its primary endpoint
He is a seasoned business leader with a successful track record of over 26 years across local and area roles within the pharmaceutical industry
Subscribe To Our Newsletter & Stay Updated
